With a community of over 300 scientists and researchers, we strive to save patients' lives through scientific testing and assay development.

Initiating clinical trials in China to support new modalities, such as cell and gene therapy and rare diseases.

We continue to support innovative therapies through the breadth and depth of our scientific expertise and global operations.

Through unmatched scientific insights and testing solutions, we provide our clients with services across the enterprise that meet their needs.

By expanding capabilities in genomics, anatomic pathology and histology, flow cytometry, and companion diagnostics and in vitro diagnostics, our central lab in Japan is poised to better serve our clients.

How do we optimize our collection procedures and ensure your investigator and site staff can meet the demands of your study?

Check out our engaging presentation where four specialists will share insights that will provide new approaches for optimizing your next ADME/hAME study.

The science behind the development of gene- and cell-based therapies is as granular as it gets. Research at this level of precision requires the latest technology, state-of-the-art facilities and expert staff to produce optimal outcomes.

Listen as Shak Ramkissoon, MD PhD, MMSc, Vice President and Medical Lead at Labcorp present on bringing the promise of precision oncology within reach for all.